~~<i id='23C5692E8B'><strike id='23C5692E8B'><tt id='23C5692E8B'><pre id='23C5692E8B'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

comprehensive

author：focus 2025-09-27 12:57:43 - browse：23

Martin Shkreli Securities Fraud Trial — Kevin Hagen/Getty Images

Is this the end of the line for the “pharma bro” with the perpetual smirk?

Martin Skhreli was found guilty on Friday of three counts of fraud after a five-week trial in federal court in Brooklyn, N.Y. He faces a prison sentence that could stretch years.

“This was a witch hunt of epic proportions,” Shkreli said outside court after the verdict, the Washington Post reported. “They may have found some broomsticks.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Second xenotransplant done with gene

explore

focus

entertainment

hotspot

explore

AlexWong/GettyImagesAmericanswhosuffersevereallergicreactionswon’thavealternativestoauto-injectorsli

WSS

What Congress can do to address the rural doctor shortage

Federal judge rules Oregon’s tough new gun law is constitutional

Why are Kaiser Permanente staff considering a strike?

Europe sees delivery challenges ahead on Alzheimer's therapies

Experts study whether long Covid risk adds up with each reinfection

Congress: Eradicate hepatitis C and reduce the deficit

Wikipedia

comprehensive

explore

The cancer drug shortage isn’t new — and neither are the solutions

Senate HELP committee spars over health care workforce policies

Jerome Adams on the need for new antivirals for Covid

Congress likely to miss an opportunity to fix drug shortages issue

Heart attack and stroke risk calculators need revising

Woman gored by Bison at Yellowstone

Bright Health sells Medicare Advantage business to Molina

RFK Jr. accused of antisemitic claims about COVID but insists he was misunderstood

What does generative AI mean for health care? We asked experts

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

focus

Drug for rare kidney disease narrowly misses mark in clinical trial

Eli Lilly to acquire Versanis in heated race for weight loss drugs

Can CDC director Mandy Cohen drive consensus in Washington?

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

Emergency workers more likely to restrain Black patients: study

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

focus

entertainment

hotspot

explore